LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Translational Development Acquisition Corp.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERTDAC
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / TDAC COVERAGE

What’s moving Translational Development Acquisition Corp. now

Current reporting with the operating signal separated from the noise.

01
Pulse 2.0

ProLogium And Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment

The story matters when it changes Translational Development Acquisition Corp.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
TradingView

Price to earnings forward of Translational Development Acquisition Corp. – NASDAQ:TDACU

Investors are testing whether Translational Development Acquisition Corp.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
dars.gov.et

Translational Development Acquisition Corp. (TDAC) Edges Higher: Stability in a Quiet Market - Volatility Skew

The story matters when it changes Translational Development Acquisition Corp.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Translational Development Acquisition Corp. Wt

Translational Development Acquisition Corp. Wt

The story matters when it changes Translational Development Acquisition Corp.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
GlobeNewswire

ProLogium and Translational Development Acquisition Corp.

The story matters when it changes Translational Development Acquisition Corp.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
06
ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination

ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination

The story matters when it changes Translational Development Acquisition Corp.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
07
Translational Development Acquisition Corp.

Translational Development Acquisition Corp.

The story matters when it changes Translational Development Acquisition Corp.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
08
Translational Development Acquisition Corp.: TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger

Translational Development Acquisition Corp.: TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger

The story matters when it changes Translational Development Acquisition Corp.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
09
Translational Development Acquisition Corp. Announces that the Separate Trading of its Class A Ordinary Shares and Warrants has Commenced

Translational Development Acquisition Corp. Announces that the Separate Trading of its Class A Ordinary Shares and Warrants has Commenced

Investors are testing whether Translational Development Acquisition Corp.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
10
Translational Development Acquisition Corp. Un

Translational Development Acquisition Corp. Un

The story matters when it changes Translational Development Acquisition Corp.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest TDAC filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-15 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-14 · Period 2025-09-30SEC ↗10-K/AAnnual financial reportFiled 2026-05-11 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-27 · Period 2026-07-27SEC ↗8-KMaterial company eventFiled 2026-07-08 · Period 2026-07-06SEC ↗8-KMaterial company eventFiled 2026-06-23 · Period 2026-06-22SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-05-27 · Period 2026-06-17SEC ↗425Official SEC filingFiled 2026-07-28SEC ↗
EARNINGS / QUARTERLY TRACKER

Translational Development Acquisition Corp., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.